Chen, J., Chou, C., Wu, Y., Yang, M., Chu, S., Chen, Y., Chao, Y., Chen, C. (2025). Preclinical development of GNTbm-38, a novel class I histone deacetylase inhibitor, while combined with anti-VEGFR TKI or anti-PD-1 Ab: Assessment of immune activation and immune memory in cancer immunotherapy.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.2574